Malnutrition
Conditions
Brief summary
Research goals include evaluating the relative impact of maternal nutritional status versus recent dietary intake on breast milk micronutrient composition, and evaluating the impact of a maternal lipid based nutrient supplement (LNS) on breast milk micronutrient composition.
Detailed description
The study includes a cross sectional and an interventional component. Maternal dietary intake and nutritional status will be compared to breast milk micronutrient composition in a cross sectional manner. The short term effect of maternal dietary intake on breast milk micronutrient composition will be examined using an intervention with a controlled diet and LNS. Infants will be test-weighed during the LNS intervention in order to calculate the infant micronutrient intake from the control and LNS intervention days. Mother-infant dyads will be recruited into the study and the order in which they will receive the 3 treatments will be randomized. All mothers will receive all treatments. The mothers will be invited to the clinic on 4 separate occasions. During the first study visit, maternal blood will be collected, anthropometric indices will be assessed, and food frequency and demographic characteristic surveys will be administered. During the 2-4 visits, the LNS intervention will take place. Mothers will arrive at the clinic fasted, and a fasted milk collection will occur. Subsequently, mothers will be provided 3 meals based on local foods with low-nutrient density. Milk will be collected for 8 hours at each infant feed (ad libitum). A 24 hour dietary recall will be conducted. Mothers will receive 1) no LNS, 2) A single dose of LNS with breakfast, or 3) A single dose of LNS split into 3 parts with their meals throughout the day. Infants will be test weighed before and after each feed to calculate their nutrient intake from breast milk and the impact of the different supplementation schemes on their nutrient intake.
Interventions
OTHERTreatment 1: Control
No supplement provided.
DIETARY_SUPPLEMENTTreatment 2: Bolus (LNS)
One LNS supplement provided in a single bolus dose in the morning
DIETARY_SUPPLEMENTTreatment 3: Divided Dose (LNS)
One LNS supplement provided in 3 separate portions throughout the study visit
Sponsors
University of California, Davis
Blum Center for Developing Economies
Fogarty International Center of the National Institute of Health
Center for the Studies of Sensory Impairment, Aging and Metabolism (CeSSIAM)
USDA, Western Human Nutrition Research Center
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* Mother 18-40 years of age * Apparently healthy, with no acute illness * Willing to stay in clinic for breast milk sampling, and adhere to all study procedures * 4-6 months of lactation and ≥ 8 breast feeding episodes per day (usual frequency is \>20 times/day) * Last birth was a singleton birth * Only breastfeeding one child * Child is 4-6 months of age
Exclusion criteria
* Current supplement use (iron + folic acid excepted) * Self reported mastitis or other breast infections * Reported problems with breastfeeding which might affect study procedures * Last birth was premature (\>4 weeks pre-term by maternal report) * Measured body mass index (BMI) of less than 18.5 or a measured mid upper arm circumference (MUAC) of less than 12.5 cm * Temporary- if the mother or her infant present with an acute illness, (for example flu or diarrhea,) they will be rescheduled to return on a later date when both are apparently healthy. * Allergy to milk, milk products, or peanuts.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Riboflavin (vitamin B2) in Breast Milk | Breast milk riboflavin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart. | We are observing the change in breast milk vitamin B2 over the course of 8 hours. |
| Change in Cobalamin (vitamin B12) in Breast Milk | Breast milk cobalamin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits/weeks 2, 3, & 4 will each be held approximately 1 week apart. | We are observing the change in breast milk vitamin B12 over the course of 8 hours. |
| Change in Pyridoxal (vitamin B6) in Breast Milk | Breast milk pyridoxal will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits/weeks 2, 3, & 4 will each be held approximately 1 week apart. | We are observing the change in breast milk vitamin B6 over the course of 8 hours. |
| Change in Niacin (vitamin B3) in Breast Milk | Breast milk niacin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart. | We are observing the change in breast milk vitamin B5 over the course of 8 hours. |
| Change in Thiamin (vitamin B1) in Breast Milk | Breast milk thiamin will be assessed in an 8-hour milk sample on each of three study visit days (Visits/weeks 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart. | We are observing the change in breast milk vitamin B1 over the course of 8 hours. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Maternal cobalamin (vitamin B12) status | Measured once prior to first study visit (week 1) | Maternal cobalamin (vitamin B12) status will be measured in blood. |
| Change in Infant Milk Consumption | Breast milk consumption for an 8-hour period will be assessed on each of three study visit days (Visits/weeks 2, 3, and 4). Study visits 2, 3, & 4 will each be held approximately 1 week apart. | Infants will be test-weighed before and after each feed to calculate milk intake during the study visits. We are observing the change in breast milk intake over the course of 8 hours. |
| Maternal pyridoxal (vitamin B6) status | Measured once prior to first study visit (week 1) | Maternal pyridoxal (vitamin B6) will be measured in blood. |
| Maternal riboflavin (vitamin B2) status | Measured once prior to first study visit (week 1) | Maternal riboflavin (vitamin B2) will be measured in blood. |
| Maternal niacin (vitamin B3) status | Measured once prior to first study visit (week 1) | Maternal niacin (vitamin B5) will be measured in blood. |
| Maternal thiamin (vitamin B1) status | Measured once prior to first study visit (week 1) | Maternal thiamin (vitamin B1) will be measured in blood. |
Countries
United States
Outcome results
None listed